Search Results - "TAKAMATSU, J"

Restock and straightening system for retail automation using compliant and mobile manipulation by Garcia Ricardez, G. A., Okada, S., Koganti, N., Yasuda, A., Uriguen Eljuri, P. M., Sano, T., Yang, P.-C., El Hafi, L., Yamamoto, M., Takamatsu, J., Ogasawara, T.

“…As the retail industry keeps expanding and shortage of workers increasing, there is a need for autonomous manipulation of products to support retail…”
Get full text

Life‐threatening hemorrhage and prolonged wound healing are remarkable phenotypes manifested by complete plasminogen activator inhibitor‐1 deficiency in humans by IWAKI, T., TANAKA, A., MIYAWAKI, Y., SUZUKI, A., KOBAYASHI, T., TAKAMATSU, J., MATSUSHITA, T., UMEMURA, K., URANO, T., KOJIMA, T., TERAO, T., KANAYAMA, N.

“…Background: Plasminogen activator inhibitor‐1 (PAI‐1) is the primary physiological regulator of urokinase plasminogen activator (uPA) and tissue plasminogen…”
Get full text

Aging and plasminogen activator inhibitor-1 (PAI-1) regulation : Implication in the pathogenesis of thrombotic disorders in the elderly by YAMAMOTO, Koji, TAKESHITA, Kyosuke, KOJIMA, Tetsuhito, TAKAMATSU, Junki, SAITO, Hidehiko

“…Thrombotic cardiovascular diseases increase in incidence in the elderly, a tendency dependent on the age-related changes in vascular and hemostatic systems…”
Get full text

A phase III clinical trial of a mixture agent of plasma‐derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors by Shinkoda, Y., Shirahata, A., Fukutake, K., Takamatsu, J., Shima, M., Hanabusa, H., Mugishima, H., Takedani, H., Kawasugi, K., Taki, M., Matsushita, T., Tawa, A., Nogami, K., Higasa, S., Kosaka, Y., Fujii, T., Sakai, M., Migita, M., Uchiba, M., Kawakami, K., Sameshima, K., Ohashi, Y., Saito, H.

“…Introduction MC710, a 1:10 protein weight ratio mixture of plasma‐derived activated factor VII (FVIIa) and factor X (FX), is a novel bypassing agent for…”
Get full text

Extraction of essential interactions through multiple observations of human demonstrations by Ogawara, K., Takamatsu, J., Kimura, H., Ikeuchi, K.

“…This paper describes a new approach on how to teach a robot everyday manipulation tasks under the "Learning from Observation" framework. In this approach,…”
Get full text

Representation for knot-tying tasks by Takamatsu, J., Morita, T., Ogawara, K., Kimura, H., Ikeuchi, K.

“…The learning from observation (LFO) paradigm has been widely applied in various types of robot systems. It helps reduce the work of the programmer. However,…”
Get full text

A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics by Shirahata, A., Fukutake, K., Takamatsu, J., Shima, M., Hanabusa, H., Mugishima, H., Amano, K., Takedani, H., Tamashima, S., Matsushita, T., Tawa, A., Tanaka, I., Higasa, S., Kosaka, Y., Fujii, T., Sakai, M., Migita, M., Kawakami, K., Ohashi, Y., Saito, H.

“…Summary MC710, a mixture of plasma‐derived activated factor VII and factor X at a protein weight ratio of 1:10, is a novel bypassing agent for haemostasis in…”
Get full text

Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors-phase I trial: 2nd report by Shirahata, A., Fukutake, K., Mimaya, J., Takamatsu, J., Shima, M., Hanabusa, H., Takedani, H., Takashima, Y., Matsushita, T., Tawa, A., Higasa, S., Takata, N., Sakai, M., Kawakami, K., Ohashi, Y., Saito, H.

“…Summary We reported the results of a clinical pharmacological study of MC710 (a mixture of plasma‐derived FVIIa and FX) in haemophilia patients with inhibitors…”
Get full text

An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan by SHIRAHATA, A., FUKUTAKE, K., HIGASA, S., MIMAYA, J., OKA, T., SHIMA, M., TAKAMATSU, J., TAKI, M., TANEICHI, M., YOSHIOKA, A.

“…Studies conducted in European and North American countries have demonstrated that various factors including races affect the frequency of inhibitor formation…”
Get full text

Polymorphism in RANTES Chemokine Promoter Affects HIV-1 Disease Progression by Liu, Huanliang, Chao, David, Nakayama, Emi E., Taguchi, Hitomi, Goto, Mieko, Xin, Xiaomi, Takamatsu, Jun-ki, Saito, Hidehiko, Ishikawa, Yoshihide, Akaza, Tatsuya, Juji, Takeo, Takebe, Yutaka, Ohishi, Takeshi, Fukutake, Katsuyuki, Maruyama, Yoshikazu, Yashiki, Shinji, Sonoda, Shunro, Nakamura, Tetsuya, Nagai, Yoshiyuki, Iwamoto, Aikichi, Shioda, Tatsuo

“…RANTES (regulated on activation normal T cell expressed and secreted) is one of the natural ligands for the chemokine recptor CCR5 and potently suppresses in…”
Get full text

Clinical pharmacological study of a plasma-derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors - Phase I trial by SHIRAHATA, A., FUKUTAKE, K., MIMAYA, J., TAKAMATSU, J., SHIMA, M., HANABUSA, H., TAKEDANI, H., TAKASHIMA, Y., MATSUSHITA, T., TAWA, A., HIGASA, S., TAKATA, N., SAKAI, M., KAWAKAMI, K., OHASHI, Y., SAITO, H.

“…MC710, a combined product of plasma‐derived activated factor VII (FVIIa) and factor X (FX) at a protein weight ratio of 1:10, is a novel bypassing agent for…”
Get full text

Consecutive national surveys of ABO-incompatible blood transfusion in Japan by Fujii, Y., Shibata, Y., Miyata, S., Inaba, S., Asai, T., Hoshi, Y., Takamatsu, J., Takahashi, K., Ohto, H., Juji, T., Sagawa, K.

“…Background and Objectives  Morbidity and mortality from ABO‐incompatible transfusion persist as consequences of human error. Even so, insufficient attention…”
Get full text

Clinical evaluation of recombinant factor VIII preparation (Kogenate) in previously treated patients with Hemophilia A : Descriptive meta-analysis of post-marketing study data by YOSHIOKA, A, FUKUTAKE, K, TAKAMATSU, J, SHIRAHATA, A

“…The safety and efficacy of Kogenate, a recombinant factor VIII (rFVIII) preparation for the treatment of bleeding episodes, were studied in a 123-patient…”
Get full text

Clinical evaluation of a recombinant factor VIII preparation (Kogenate) in previously untreated patients with hemophilia A by YOSHIOKA, A, FUKUTAKE, K, TAKAMATSU, J, SHIRAHATA, A

“…The safety and efficacy of a recombinant factor VIII (rFVIII) preparation (Kogenate) for the treatment of bleeding episodes was studied in previously untreated…”
Get full text

In vitro characterization of missense mutations associated with quantitative protein S deficiency by OKADA, H., YAMAZAKI, T., TAKAGI, A., MURATE, T., YAMAMOTO, K., TAKAMATSU, J., MATSUSHITA, T., NAOE, T., KUNISHIMA, S., HAMAGUCHI, M., SAITO, H., KOJIMA, T.

“…Objective: To elucidate the molecular consequences of hereditary protein S (PS) deficiency, we investigated the in vitro synthesis of the PS missense mutants…”
Get full text

Anti‐HCV agent, ribavirin, elevates the activity of clotting factor VII in patients with hemophilia: a possible mechanism of decreased events of bleeding in patients with hemophilia by ribavirin by YAMAMOTO, K., HONDA, T., MATSUSHITA, T., KOJIMA, T., TAKAMATSU, J.

Get full text

Obesity enhances the induction of plasminogen activator inhibitor‐1 by restraint stress: a possible mechanism of stress‐induced renal fibrin deposition in obese mice by YAMAMOTO, K., KOJIMA, T., ADACHI, T., HAYASHI, M., MATSUSHITA, T., TAKAMATSU, J., LOSKUTOFF, D. J., SAITO, H.

“…Background and objectives: Cardiovascular/thrombotic diseases are frequently induced by a variety of stressors. Obese patients are susceptible to thrombotic…”
Get full text

Pitavastatin attenuates the upregulation of tissue factor in restraint-stressed mice by Yamamoto, K, Kojima, T, Takeshita, K, Matsushita, T, Takamatsu, J

Get full text

Breed differentiation among Japanese native chickens by specific skull features determined by direct measurements and computer vision techniques by Ino, Y, Oka, T, Nomura, K, Watanabe, T, Kawashima, S, Amano, T, Hayashi, Y, Okabe, A, Uehara, Y, Masuda, T

“…1. Inter-breed morphological comparisons were made among 11 breeds of Japanese native chickens (Gifujidori, Hinaidori, Shokoku, Totenko, Tomaru, Satsumadori,…”
Get full text

Restriction of dietary Iodine does not ameliorate the early effect of anti-thyroid drug therapy for Graves' disease in an area of excessive iodine intake by Hiraiwa, T, Ito, M, Imagawa, A, Takamatsu, J, Kuma, K, Miyauchi, A, Hanafusa, T

“…The close relationship between iodine intake and the effects of anti-thyroid drugs (ATD) for Graves' disease (GD) has been well established. However, it…”
Get full text